Session Three of Defeat Duchenne Canadian Conference Addressing Standards of Care in Canada to Take Place December 3rd and 4th

The NMD4C is proud to partner with Jesse’s Journey and Muscular Dystrophy Canada (MDC) in hosting the first national summit solely focused on DMD for health care providers across Canada, with the theme for this year’s event being ‘Addressing DMD Standards of Care in Canada’. We have brought together subject matter experts from pediatric and adult care for a comprehensive overview of the Canadian adaptation to the international DMD care considerations published in 2018.

Don’t forget to register for the third and final session of the CPD-accredited Defeat Duchenne Canadian Conference, which will take place on the 3rd and 4th of December, 2021 with sessions on Orthopedic Management and Rehabilitation Management in Duchenne on December 3rd, and Psychosocial Management and Duchenne and the Brain on December 4th.

Thank you to everyone from our community who completed the pre-event Canadian Duchenne standards of care survey. The results from the survey will be used as a springboard for discussion during the event and prepared for publication thereafter. We hope to see you at the conference!

Register for session three here!

 

 

Day 1: Friday, December 3, 2021

11 a.m. – 12:30 p.m. ET: Orthopedic Management in Duchenne

Moderator:

Co-Leads/Speakers:

  • Dr. Chris Reilly (Pediatric Orthopedic Surgeon)
  • Dr. Patricia Larouche (Pediatric Orthopedic Surgeon)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care in orthopedic management across Canada.
  • Understand lived experience of orthopedic care from people with Duchenne and their families.
  • Participate in insightful discussion to identify and provide recommendations on how to address current gaps in Duchenne standards of care for orthopedic care.

 

12:30 – 2 p.m. ET: Rehabilitation Management in Duchenne

Moderator:

Co-Leads/Speakers:

  • Dr. Sue Dojeiji (Adult Physiatrist)
  • Dr. Jordan Sheriko (Medical Director of Pediatric Rehabilitation)

Speakers:

  • Dr. Anna McCormick (Pediatrician & Pediatric Physiatrist)
  • Charise MacDonald (Occupational Therapist)
  • Dr. Michael Berger (Adult Physiatrist)

Panelists:

  • Sarah Moore (Recreational Therapist)
  • Khalid Mahdi (DMD Adult)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care in rehabilitation management.
  • Understand lived experience of rehabilitation services from people with Duchenne and their families.
  • Participate in insightful discussions to identify and provide recommendations on how to address current gaps in Duchenne standards of care in rehabilitation management.

 

Day 2: Saturday, December 4, 2021

11 a.m. – 12:30 p.m. ET: Duchenne and the Brain

Moderator/Lead:

Speakers:

  • Dr. Francesco Muntoni (Professor Pediatric Neurology) – Keynote Speaker
  • Dr. Veronica Hinton (Professor of Psychology)

Panelists:

  • Debra Chiabai (DMD Parent)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care involving the brain across Canada.
  • Understand lived experience involving the brain from people with Duchenne and their families.
  • Participate in insightful discussion to identify and provide recommendations on how to address current gaps in Duchenne standards of care involving the brain.

 

12:30 – 2 p.m. ET: Psychosocial Management

Moderator:

Co-Leads/Speakers:

  • Dr. Jean Mah (Pediatric Neurologist)
  • Dr. Stephanie Plamondon (Adult Physiatrist)

Panelist:

  • Debra Chiabai (DMD Parent)
  • Zoe Schwartz (Pediatric Social Worker)

Learning Objectives:

  • Learn about the current landscape of Duchenne standards of care in psychosocial management across Canada.
  • Understand lived experience of psychosocial management from people with Duchenne and their families.
  • Participate in insightful discussion to identify and provide recommendations on how to address current gaps in Duchenne standards of care for psychosocial management.
DDCC21_speakers_poster

Read next...

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

Muscular Dystrophy Canada Launches Initiative to Improve Genetic Testing Access for Myotonic Dystrophy

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

LEARNMD content update - February 2025

New Content Available in LEARNMD

LEARNMD is the NMD4C’s online educational platform, offering talks and sessions on a wide range of neuromuscular topics presented by leading clinical and scientific experts worldwide. We’re excited to share what’s new on LEARNMD in February 2025!

RQAS logo

Quebec Network Réseau Québécoise de l’Amyotrophie Spinale Joins NMD4C as Community of Practice Sub-Group

We are thrilled to announce that the RQAS, a network uniting rehabilitation clinicians across Quebec to advance the care of people with Spinal Muscular Atrophy has officially become a sub-group Community of Practice of the NMD4C

2024 year in review

NMD4C 2024 Year in Review

This year in review outlines a collection of achievements from the network over the past year.

2025 NM fellowship funding recipients

NMD4C and MDC Award Fellowship Funding in NMD Research and Medicine

Together the Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are excited to announce the 2025 recipients of our neuromuscular fellowship funding competition to award postdoctoral fellowships in neuromuscular disease (NMD) research and clinical fellowships in neuromuscular medicine and electromyography!

Meet the Basic Science Trainee Committee

NMD4C Basic Science Trainee Committee Provides Leadership Opportunity for Next Generation of Neuromuscular Researchers

The newly-formed Basic Science Trainee Committee represents the interests of trainees within the network, offering an opportunity for professional growth for future leaders in neuromuscular research.